Shanghai Sanyou Medical Co., Ltd

SHSE:688085 Stock Report

Market Cap: CN¥5.1b

Shanghai Sanyou Medical Future Growth

Future criteria checks 5/6

Shanghai Sanyou Medical is forecast to grow earnings and revenue by 45.2% and 28.5% per annum respectively. EPS is expected to grow by 46.8% per annum. Return on equity is forecast to be 7.4% in 3 years.

Key information

45.2%

Earnings growth rate

46.8%

EPS growth rate

Medical Equipment earnings growth26.5%
Revenue growth rate28.5%
Future return on equity7.4%
Analyst coverage

Low

Last updated02 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings Troubles May Signal Larger Issues for Shanghai Sanyou Medical (SHSE:688085) Shareholders

Nov 04
Earnings Troubles May Signal Larger Issues for Shanghai Sanyou Medical (SHSE:688085) Shareholders

Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) 26% Jump Shows Its Popularity With Investors

Oct 28
Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) 26% Jump Shows Its Popularity With Investors

Returns On Capital Signal Tricky Times Ahead For Shanghai Sanyou Medical (SHSE:688085)

Oct 01
Returns On Capital Signal Tricky Times Ahead For Shanghai Sanyou Medical (SHSE:688085)

Shanghai Sanyou Medical's (SHSE:688085) Soft Earnings Are Actually Better Than They Appear

May 02
Shanghai Sanyou Medical's (SHSE:688085) Soft Earnings Are Actually Better Than They Appear

Calculating The Fair Value Of Shanghai Sanyou Medical Co., Ltd (SHSE:688085)

Apr 16
Calculating The Fair Value Of Shanghai Sanyou Medical Co., Ltd (SHSE:688085)

Market Participants Recognise Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) Earnings Pushing Shares 25% Higher

Mar 04
Market Participants Recognise Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) Earnings Pushing Shares 25% Higher

Earnings and Revenue Growth Forecasts

SHSE:688085 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026880180N/A2372
12/31/2025700152N/A1082
12/31/2024559111N/A-22
9/30/20244343883106N/A
6/30/202439034111138N/A
3/31/202438659144178N/A
12/31/202346096241267N/A
9/30/2023527132161227N/A
6/30/202363517788194N/A
3/31/202368019260179N/A
12/31/202264919118156N/A
9/30/202265619855183N/A
6/30/202262919391200N/A
3/31/202260519070163N/A
12/31/202159318653145N/A
9/30/20215401522572N/A
6/30/20215011513467N/A
3/31/20214591373071N/A
12/31/20203901194778N/A
9/30/20203681053185N/A
6/30/202034486-1749N/A
3/31/202033290-2657N/A
12/31/201935498-1862N/A
12/31/201822262-4120N/A
12/31/20171405N/A22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688085's forecast earnings growth (45.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 688085's earnings (45.2% per year) are forecast to grow faster than the CN market (26.3% per year).

High Growth Earnings: 688085's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688085's revenue (28.5% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 688085's revenue (28.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688085's Return on Equity is forecast to be low in 3 years time (7.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y